Related Experiment Video

Updated: Jul 17, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno

P Gaede1, P Vedel, H H Parving

  • 1Steno Diabetes Centre, Gentofte, Copenhagen, Denmark.

Lancet (London, England)
|February 25, 1999
PubMed
Abstract

Insights

Intensive treatment for type 2 diabetes with microalbuminuria significantly reduced progression of nephropathy, retinopathy, and neuropathy. This multifactorial approach offers a promising strategy for managing diabetic complications.

Area of Science:

  • Endocrinology
  • Nephrology
  • Ophthalmology

Background:

  • Type 2 diabetes mellitus (T2DM) complications are multifactorial.
  • Microalbuminuria is an early indicator of diabetic kidney disease.
  • Risk factor management is crucial for T2DM patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of stepwise intensive risk factor treatment versus standard treatment in T2DM patients with microalbuminuria.
  • To assess the impact on the progression of nephropathy, retinopathy, and neuropathy.

Main Methods:

  • A randomized, open, parallel trial comparing standard (n=80) and intensive (n=80) treatment groups.
  • Intensive treatment involved stepwise behavior modification and pharmacological interventions for hyperglycemia, hypertension, dyslipidemia, and microalbuminuria.
  • Primary endpoint: development of nephropathy; Secondary endpoints: progression of retinopathy and neuropathy.

Main Results:

  • Patients in the intensive group showed significantly lower rates of progression to nephropathy (OR 0.27).
  • Intensive treatment also reduced the progression of retinopathy (OR 0.45) and autonomic neuropathy (OR 0.32).
  • Follow-up duration was 3.8 years with a mean patient age of 55.1 years.

Conclusions:

  • Intensified multifactorial intervention effectively slows the progression of nephropathy, retinopathy, and autonomic neuropathy in T2DM patients with microalbuminuria.
  • Further research is required to determine the long-term effects on macrovascular complications and mortality.

More Related Videos

Static Strength Training Method for Type 2 Diabetic Mice03:17

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...